Insight Molecular Diagnostics Inc. · IMDX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $25.76M − (Liabilities $57.22M + Equity -$31.46M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$11.58M
45.0%
$2.95M
34.1%
Assets
Receivables
$1.13M
4.4%
-$485.00K
-30.1%
Assets
Other current assets
$2.15M
8.3%
$1.05M
95.4%
Assets
PPE
$2.82M
10.9%
$58.00K
2.1%
Assets
Other
$8.08M
31.4%
-$12.89M
-61.5%
Liabilities + Equity
Accounts payable
$2.54M
9.9%
$265.00K
11.6%
Liabilities + Equity
Short-term debt
$1.81M
7.0%
$512.00K
39.5%
Liabilities + Equity
Other liabilities
$52.87M
205.3%
$9.09M
20.8%
Liabilities + Equity
Equity
-$31.46M
-122.2%
-$19.19M
-156.3%